Omaveloxolone is a semi-synthetic triterpenoid compound that functions as an Nrf2 activator. It is approved as a pharmaceutical raw material for use in Friedreich's ataxia in adults and adolescents aged 16 years and older.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Omaveloxolone?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Pitavastatin calcium
pharmaceutical raw material
Bosentan
pharmaceutical raw material
Desethylchloroquine
pharmaceutical raw material
Calcipotriene hydrate
pharmaceutical raw material
The international HS code for Omaveloxolone (CAS 1474034-05-3) is 2926.90.
2926.90
2926 90 70
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicen-4a-yl]-2,2-difluoropropanamide
RJCWBNBKOKFWNY-IDPLTSGASA-N
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F
Sourcing Omaveloxolone?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.